Overview
Funding Rounds 2
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
| Jul 13, 2010 | Series B round | $22M |
Mentions in press and media 7
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Nov 6, 2012 | Tests that can assess aggressiveness of a patient’s prostate cancer and its course raise $13M | Solution/product: The company is developing two diagnostics for prostate cancer, according to a company statement. Its lead test is designed to use prostate cancer biopsy tissue to help physicians more accurately determine if patients have ... |
| Nov 6, 2012 | Metamark Genetics Closes $13M Series B Financing | Metamark Genetics, Inc., a Cambridge, Mass.-based oncology-focused molecular diagnostics company, has closed a $13m Series B financing. The round was led by current and new private investors. The company intends to use the proceeds to furth... |
| Nov 15, 2010 | Personnel moves: Covidien pharma president Wright bows out | Covidien pharma president Wright bows out Timothy Wright resigned as Covidien plc’s (NYSE:COV) senior vice president and president of its pharmaceuticals segment, effective Dec. 2, according to a Securities & Exchange Commission filing.... |
| Jul 14, 2010 | Metamark Genetics reels in $22 million in Series B round | Metamark Genetics Inc. completed its Series B round to expand the company’s R&D operation and clinical testing facilities. The Naples, Fla.-based firm, which has operations in Cambridge, Mass., raised $22 million from three investors in... |
| Jul 13, 2010 | Metamark Genetics Completes $22M Series B Financing | Metamark Genetics, Inc., an oncology company focused on the development of function-based prognostic assays for early staged cancers, has completed a $22m Series B financing. The company is currently developing prognostic diagnostic tests (... |
| Tests that can assess aggressiveness of a patient’s prostate cancer and its course raise $13M | Company name: Metamark Genetics Industry: Oncology/medical device Location: Cambridge, Massachusetts Solution/product: The company is developing two diagnostics for prostate cancer, according to a company statement. Its lead test is designe... |
Reviews 0
FAQ about Local index
When was Local index founded?
Local index was founded in 2007.
How much funding has Local index raised?
Local index has raised $35M in total across 2 funding rounds.
What funding rounds has Local index raised?
Parsers VC lists 2 funding rounds of Local index, among them a Series B round of $22M on Jul 13, 2010.
What has the press written about Local index?
Parsers VC has collected 7 articles mentioning Local index, among them “Tests that can assess aggressiveness of a patient’s prostate cancer and its course raise $13M” (Nov 6, 2012) and “Metamark Genetics Closes $13M Series B Financing” (Nov 6, 2012).
Is Local index still active?
Yes, Local index is active; its latest activity on Parsers VC dates from Nov 16, 2012.